key: cord-0946910-ihtzvalb authors: Chirumbolo, Salvatore title: Antioxidants associated with NSAIDs might even exacerbate the progress of SARS‐CoV2 disease date: 2021-11-20 journal: J Med Virol DOI: 10.1002/jmv.27455 sha: 5fe4c0e0be39f5bea2b931e30ac63d521d457742 doc_id: 946910 cord_uid: ihtzvalb nan imbalance in the ROS signaling, which should lead to damages for the organism and might result in several pathological disorders. 1 The widespread use of herbal and nature-derived compounds associated with nonsteroidal anti-inflammatory drugs (NSAIDs), to relieve early or mild symptoms in coronavirus disease 2019 (COVID-19) positive patients, might exacerbate the progress of the disease, even leading to chronic impairments and post-acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) sequelae (PASC), which a redox imbalance has been suggested to be associated with. 4 Actually, the action of the excess antioxidant compounds on the endothelial redox mechanisms, while SARS-CoV2 is acting, may cause redox imbalance. Flavonoids, actually, target endothelia, by modifying their physiology. 5 So far, there is no clinical evidence about the ability of antioxidants to progress COVID-19 towards PASC; notwithstanding, the abuse of these substances, commonly considered completely harmless, may affect the potential of NSAIDs to rescue a complete health status. This consideration comes from deeply observing the mechanisms underlying the activity of supplement anti-oxidants associated with anti-inflammatory drugs in the early treatment of COVID-19. Furthermore, previous evidence has reported that antioxidant supplements may act as ROS enhancers, if regularly assumed with pharmaceuticals and therefore exceeding the usual recommended dosage from raw food 6,7 and moreover ROS increase promotes venous thrombotic events. 7 Anyway, even the purported reduction of oxidative stress in endothelia and platelets, attributed primarily to the action of an enforced antioxidant supplementation, may promote thrombosis. The first major consideration is that ROS are crucial signaling molecules for the platelet-mediated modulation of thrombotic events. 8 Cell redox homeostasis has a leading role in preventing damage to the organism. 9 Adjusting the correct level of intracellular ROS, for example, is particularly important for the signaling of the mitogen-activated protein (MAP) kinase pathways in platelets. 10 MAP kinases are a family of at least four major components, namely the extracellular signal-related kinases 1 and 2 (Erk ½), the p38 kinase (p38MAPK), the c-jun N-terminal kinase (JKN1), and the big MAP kinase 1 or Erk5 (BMK1/Erk5). This latter is particularly crucial for the platelet function. The kinase Erk5 is expressed by platelets, its expression is finely regulated by ROS, and moreover, Erk5 acts as a keen sensor of the ROS level in platelets. 10 Upon ROS depletion, due to a strong antioxidant event, the role of Erk5 is impaired and platelet cannot tune their function on ROS signaling, so oxidized-low density lipoproteins activate platelet pro-thrombotic and pro-coagulant mechanisms via the CD36 receptor without the modulating activity of Erk5. 10,11 A marked reduction in ROS, activates mitochondria oxidative phosphorylation (OXPHOS), particularly in platelet mitochondria, which play an utmost role in platelet function. 12 When platelet mitochondria are particularly stressed, due to an increase in ATP production, ROS and calcium efflux, apoptotic mechanisms may occur, 11 so producing platelet microparticles (PMPs), which are particularly active in thrombogenic mechanisms and can promote macrophage switching towards a pro-inflammatory M1 phenotype. 13 The apoptotic signal is particularly concerning if the cellular milieu is highly stressed, as occurring in platelet deficient of ROS signaling. Delayed (not early) pro-thrombotic mechanisms and the prolonged activation of a pro-inflammatory status, might lengthen the SARS-CoV2 symptoms, and, at least theoretically, may reach possible PASC with fatigue. 14 How this might occur? NSAIDs are able to reduce SARS-CoV2-related inflammation but the concurrent prolonged use of diet supplements should trigger antioxidative stress, particularly during the associated therapy formulation. 15 (1) while an NSAID has both an antiaggregant and anti-inflammatory action, (2) the antioxidant supplement can induce a dysregulated CD36 function, and depletion of ROS, with an impairment in platelets mitochondria function, apoptosis and hence PMPs release, (3) which can switch monocytes and macrophages to the M1 pro-inflammatory phenotype. This may lead to a delayed micro-thrombosis and possibly to symptoms collectively gathered in the term PASC (or post-COVID). NSAID, nonsteroidal anti-inflammatory drug; PASC, post-acute severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) sequelae; PMPs, platelet micro-particles; ROS, reactive oxygen species Achieving the balance between ROS and antioxidants: when to use the synthetic antioxidants Antioxidative stress Potential health impacts of excessive flavonoid intake Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome Flavonoid-induced morphological modifications of endothelial cells through microtubule stabilization Free radicals, antioxidants in disease and health Oxidative stress and thrombosis during aging: the roles of oxidative stress in RBCs in venous thrombosis Regulation of platelet activation and thrombus formation by reactive oxygen species Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein Role of platelet mitochondria: life in a nucleus-free zone Microparticles from apoptotic platelets promote resident macrophage differentiation Long-COVID and Post-COVID health complications: an up-to-date review on clinical conditions and their possible molecular mechanisms Idiosyncratic NSAID drug induced oxidative stress Paracetamol in the home treatment of early COVID-19 symptoms: a possible foe rather than a friend for elderly patients Nutraceuticals and dietary supplements should not be used to treat COVID-19 as pharmaceuticals